
Silakan coba pencarian lain
YTD | 3Bln | 1T | 3Thn | 5T | 10T | |
---|---|---|---|---|---|---|
Pertumbuhan 1000 | 976 | 1078 | 1154 | 1959 | 3048 | 4208 |
Imbal Hasil Dana | -2.36% | 7.82% | 15.37% | 25.12% | 24.97% | 15.45% |
Posisi di kategori | 41 | 17 | 72 | 43 | 8 | 5 |
% di kategori | 38 | 12 | 77 | 55 | 12 | 18 |
Nama | Peringkat | Total Aset | YTD% | 3T% | 10T% | |
---|---|---|---|---|---|---|
Reliance Small Cap Fund Dir Div | 630,07B | -0,36 | 31,56 | 23,13 | ||
Reliance Small Cap Fund Bonus | 630,07B | -0,73 | 30,49 | 21,97 | ||
Reliance Small Cap Fund Dividend | 630,07B | -1,44 | 29,60 | 22,19 | ||
Reliance Small Cap Fund Growth | 630,07B | -0,73 | 30,49 | 21,97 | ||
Reliance Small Cap Fund Dir Bon | 630,07B | -0,36 | 31,56 | 23,13 |
Nama | Peringkat | Total Aset | YTD% | 3T% | 10T% | |
---|---|---|---|---|---|---|
Reliance Pharma Fund - Bonus | 83,52B | -1,55 | 25,78 | 14,50 | ||
Reliance Pharma Fund - Growth | 83,52B | -1,55 | 25,78 | 14,50 | ||
Reliance Pharma Direct Bonus | 83,52B | -1,11 | 26,91 | 15,53 | ||
Reliance Pharma Direct Growth | 83,52B | -1,11 | 26,91 | 15,53 | ||
Reliance Pharma Dir Div Payout | 83,52B | -1,82 | 26,43 | 16,29 |
Nama | ISIN | Bobot % | Terakhir | Perubahan % | |
---|---|---|---|---|---|
Sun Pharma | INE044A01036 | 12,57 | 1.672,00 | +0,57% | |
Divi's Labs | INE361B01024 | 9,49 | 6.835,00 | -0,14% | |
Lupin | INE326A01037 | 5,82 | 1.894,70 | -0,01% | |
Cipla | INE059A01026 | 5,62 | 1.485,00 | +0,49% | |
Dr Reddy’s Laboratories | INE089A01031 | 5,49 | 1.254,70 | -0,63% |
Jenis | Harian | Mingguan | Bulanan |
---|---|---|---|
Moving Average | Beli | Beli | Beli |
Indikator Teknikal | BELI | Sangat Beli | BELI |
Rangkuman | Beli | Sangat Beli | Beli |
Anda yakin ingin memblokir %USER_NAME%?
Jika ya, Anda dan %USER_NAME% tidak akan dapat melihat posting satu sama lain di Investing.com.
%USER_NAME% berhasil dimasukkan ke Daftar Blokir Anda
Karena Anda baru saja membatalkan blokir pengguna ini, Anda harus menunggu 48 jam sebelum kembali memblokir.
Menurut saya, komentar ini:
Terima Kasih!
Laporan Anda telah terkirim untuk ditinjau oleh moderator kami